HomeCompareINZY vs STAG

INZY vs STAG: Dividend Comparison 2026

INZY yields 50.00% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INZY wins by $375.7K in total portfolio value
10 years
INZY
INZY
● Live price
50.00%
Share price
$4.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$394.0K
Annual income
$79,849.97
Full INZY calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — INZY vs STAG

📍 INZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINZYSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INZY + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
INZY pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INZY
Annual income on $10K today (after 15% tax)
$4,250.00/yr
After 10yr DRIP, annual income (after tax)
$67,872.47/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, INZY beats the other by $67,479.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INZY + STAG for your $10,000?

INZY: 50%STAG: 50%
100% STAG50/50100% INZY
Portfolio after 10yr
$206.2K
Annual income
$40,156.09/yr
Blended yield
19.48%
📊

Analyst Conviction Gap

Where Wall Street is split right now

INZY
Analyst Ratings
6
Buy
3
Hold
Consensus: Buy
Price Target
$12.00
+200.0% upside vs current
Range: $4.00 — $16.00
Altman Z
-6.5
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INZY buys
0
STAG buys
0
No recent congressional trades found for INZY or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINZYSTAG
Forward yield50.00%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$394.0K$18.3K
Annual income after 10y$79,849.97$462.22
Total dividends collected$314.4K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$12.00$45.00

Year-by-year: INZY vs STAG ($10,000, DRIP)

YearINZY PortfolioINZY Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$15,700$5,000.00$10,665$345.09+$5.0KINZY
2$24,135$7,336.45$11,364$357.70+$12.8KINZY
3$36,365$10,540.42$12,098$370.43+$24.3KINZY
4$53,753$14,842.48$12,869$383.28+$40.9KINZY
5$78,020$20,504.11$13,677$396.23+$64.3KINZY
6$111,295$27,813.68$14,524$409.27+$96.8KINZY
7$156,166$37,080.39$15,411$422.41+$140.8KINZY
8$215,724$48,626.29$16,339$435.61+$199.4KINZY
9$293,602$62,776.77$17,311$448.89+$276.3KINZY
10$394,004$79,849.97$18,327$462.22+$375.7KINZY

INZY vs STAG: Complete Analysis 2026

INZYStock

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Full INZY Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this INZY vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INZY vs SCHDINZY vs JEPIINZY vs OINZY vs KOINZY vs MAININZY vs PLDINZY vs EQRINZY vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.